Brown A E, Jackson B, Fuller S A, Sheffield J, Cannon M A, Lane J R
Combined Military Diagnostic Retrovirology Service, Rockville, Maryland, USA.
Transfusion. 1997 Sep;37(9):926-9. doi: 10.1046/j.1537-2995.1997.37997454019.x.
Assays for human immunodeficiency virus (HIV) antibody testing are characterized by very high levels of sensitivity and specificity. Nonetheless, serologic testing of HIV-infected individuals before they produce multispecific HIV antibodies will not detect and confirm those individuals as positive for HIV. This study was carried out to determine whether viral RNA in such specimens is detectable in a quantitative RNA polymerase chain reaction assay.
Study specimens were identified through the United States military HIV testing program. Thirty-five individuals were studied whose HIV type 1 (HIV-1) infection status was serologically inconclusive at initial testing (i.e., reactive on enzyme immunoassay, nondiagnostic or nonreactive on Western blot), but who were documented to be infected (n = 15) or uninfected (n = 20) through the testing of subsequently collected (follow-up) sera. HIV-1 RNA was detected in sera by the use of a commercially available, quantitative, reverse transcriptase-polymerase chain reaction assay.
Specimens from 15 individuals subsequently confirmed to be positive for HIV antibody were all positive for HIV-1 RNA. Specimens from 19 of 20 individuals subsequently confirmed to be negative for HIV antibody were negative for HIV-1 RNA. In the one HIV-1 RNA-positive serum from this group, the RNA copy number was low; specimen contamination during prior laboratory testing was suspected.
Viral RNA was detected in specimens collected for serologic diagnosis of HIV infection in which no special precautions had been taken to preserve the nucleic acid. Such molecular methods potentially add a much needed tool to current HIV testing algorithms.
人类免疫缺陷病毒(HIV)抗体检测试验具有非常高的灵敏度和特异性。然而,在HIV感染个体产生多特异性HIV抗体之前进行血清学检测,无法检测并确认这些个体为HIV阳性。本研究旨在确定在定量RNA聚合酶链反应试验中能否检测出此类标本中的病毒RNA。
通过美国军方HIV检测项目确定研究标本。研究了35名个体,其初始检测时HIV-1感染状态血清学结果不确定(即酶免疫测定呈反应性,免疫印迹法非诊断性或无反应性),但后续采集(随访)血清检测证实感染(n = 15)或未感染(n = 20)。使用市售的定量逆转录酶-聚合酶链反应试验检测血清中的HIV-1 RNA。
随后证实HIV抗体阳性的15名个体的标本,HIV-1 RNA均为阳性。随后证实HIV抗体阴性的20名个体中,19人的标本HIV-1 RNA为阴性。该组中一份HIV-1 RNA阳性血清的RNA拷贝数较低,怀疑是之前实验室检测时标本受到污染。
在未采取特殊核酸保存措施的用于HIV感染血清学诊断的标本中检测到了病毒RNA。此类分子方法可能为当前HIV检测算法增添一项急需的工具。